Intracellular GPCR modulators enable precision pharmacology.

NPJ drug discovery Pub Date : 2025-01-01 Epub Date: 2025-05-12 DOI:10.1038/s44386-025-00011-8
Brian E Krumm, Bryan L Roth
{"title":"Intracellular GPCR modulators enable precision pharmacology.","authors":"Brian E Krumm, Bryan L Roth","doi":"10.1038/s44386-025-00011-8","DOIUrl":null,"url":null,"abstract":"<p><p>G-protein-coupled receptors (GPCRs) have proven to be the most successful target class for drug discovery but their complicated signal transduction pathways cause difficulties for drug development. Recently, ligands have been identified that engage an intracellular binding site which promotes pathway biased signal in cooperation with orthosteric ligands. Here, we explore the topic of biased signaling and intracellular modulators to understand their application for precision pharmacology of Class A or Rhodopsin-Like GPCRs.</p>","PeriodicalId":520448,"journal":{"name":"NPJ drug discovery","volume":"2 1","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069105/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"NPJ drug discovery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1038/s44386-025-00011-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/12 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

G-protein-coupled receptors (GPCRs) have proven to be the most successful target class for drug discovery but their complicated signal transduction pathways cause difficulties for drug development. Recently, ligands have been identified that engage an intracellular binding site which promotes pathway biased signal in cooperation with orthosteric ligands. Here, we explore the topic of biased signaling and intracellular modulators to understand their application for precision pharmacology of Class A or Rhodopsin-Like GPCRs.

细胞内GPCR调节剂使精确药理学。
g蛋白偶联受体(gpcr)已被证明是最成功的药物发现靶标类别,但其复杂的信号转导途径给药物开发带来了困难。最近,已经发现配体参与细胞内结合位点,与正位配体合作促进通路偏倚信号。在这里,我们探讨了偏导信号和细胞内调节剂的主题,以了解它们在A类或视紫红质样gpcr的精确药理学中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信